[Federal Register Volume 83, Number 13 (Friday, January 19, 2018)]
[Notices]
[Page 2802]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00824]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD
Prevention and Treatment
AGENCY: Health Resources and Service Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Centers for Disease Control and Prevention
(CDC)/Health Resources and Services Administration (HRSA) Advisory
Committee on HIV, Viral Hepatitis and STD Prevention and Treatment will
hold a public meeting.
DATES: February 22, 2018, 2:00 p.m. to 4:00 p.m. ET.
ADDRESSES: This teleconference meeting will accommodate up to 100
attendees. Parties may access the teleconference by dialing 888-989-
6421 and using participant code 9874492. Participants should call and
connect 15-minutes prior to the start of the meeting.
FOR FURTHER INFORMATION CONTACT: Anyone requesting information
regarding the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and
STD Prevention and Treatment should contact CDR Holly Berilla, Senior
Public Health Analyst, Division of Policy and Data (DPD), HIV/AIDS
Bureau (HAB), HRSA, in one of three ways: (1) Mail a request to CDR
Holly Berilla, Senior Public Health Analyst, HRSA/HAB/DPD, 5600 Fishers
Lane, 09N156, Rockville, Maryland 20857; (2) call 301-443-9965; or (3)
send an email to [email protected].
SUPPLEMENTARY INFORMATION: The CDC/HRSA Advisory Committee on HIV,
Viral Hepatitis and STD Prevention and Treatment was established under
Section 222 of the Public Health Service (PHS) Act, [42 U.S.C. Section
217a], as amended.
The purpose of the CDC/HRSA Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and Treatment is to advise the Secretary,
HHS; the Director, CDC; and the Administrator, HRSA regarding
objectives, strategies, policies, and priorities for HIV, viral
hepatitis, and other STDs; prevention and treatment efforts including
surveillance of HIV infection, AIDS, viral hepatitis, and other STDs,
and related behaviors; epidemiologic, behavioral, health services, and
laboratory research on HIV, viral hepatitis, and other STDs;
identification of policy issues related to HIV/viral hepatitis/STD
professional eduction, patient healthcare delivery, and prevention
services; Agency policies about prevention of HIV, viral hepatitis and
other STDs; treatment, healthcare delivery, and research and training;
strategic issues influencing the ability of CDC and HRSA to fulfill
their missions of providing prevention and treatment services;
programmatic efforts to prevent and treat HIV, viral hepatitis, and
other STDs; and support to the Agencies in their developoment of
responses to emerging health needs related to HIV, viral hepatitis, and
other STDs. Information about the Committee and the meeting agenda is
available by contacting CDR Holly Berilla at the contact information
above.
During the meeting, the CDC/HRSA Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and Treatment will discuss workgroup
reports and updates, information regarding the National Ryan White HIV/
AIDS Program Conference, and Committee business-related items. Agenda
items are subject to change as priorities dictate.
Due to the nature and time limitations of the meeting, members of
the public will not have an opportunity to provide oral comments,
although written comments may be submitted to CDR Holly Berilla at the
contact information listed above at least 10 days prior to the meeting.
Individuals who need special assistance should notify CDR Holly Berilla
at the contact information listed above at least 10 days prior to the
meeting.
Amy McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2018-00824 Filed 1-18-18; 8:45 am]
BILLING CODE 4165-15-P